HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

N-(beta-(4-diazophenyl)ethyl)maleimide

used in developing enzyme immunoassay for neurotensin; structure given in first source

Also Known As:

DPEM

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Azoles: 2138
    - Pyrroles: 369
      - Maleimides: 16
        N-(beta-(4-diazophenyl)ethyl)maleimide: 2

Experts

1.	Chatterjee, Nilanjan: 1 article (10/2008)
2.	Glass, Andrew G: 1 article (10/2008)
3.	Ioffe, Olga B: 1 article (10/2008)
4.	Lacey, James V: 1 article (10/2008)
5.	Langholz, Bryan: 1 article (10/2008)
6.	Mutter, George L: 1 article (10/2008)
7.	Nucci, Marisa R: 1 article (10/2008)
8.	Richesson, Douglas A: 1 article (10/2008)
9.	Ronnett, Brigitte M: 1 article (10/2008)
10.	Rush, Brenda B: 1 article (10/2008)

Related Diseases

1.	Neoplasms (Cancer) 10/15/2008 - "Index biopsies with original community pathology diagnoses of disordered proliferative endometrium (DPEM) or EH that were independently confirmed by a panel of pathologists were independently reviewed and assigned EIN classifications (inadequate, benign, EIN, or cancer) by a second panel of pathologists. "
2.	Hyperplasia 10/15/2008 - "In the WHO system, the RR for atypical hyperplasia (AH) versus DPEM, simple hyperplasia, or complex hyperplasia was 9.19 (95% CI, 3.87-21.83). "
3.	Carcinoma (Carcinomatosis) 01/15/2008 - "With disordered proliferative endometrium (DPEM) as the referent, AH significantly increased carcinoma risk (RR=14, 95% CI, 5-38). "